|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 7/00 | (2018.01) |
| A61K 38/17 | (2006.01) | ||
| C12N 15/62 | (2006.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 7/06 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| C07K 14/41 | (2006.01) | ||
| A61P 7/06 | (2018.01) | ||
| A61K 38/00 | (2013.01) | ||
| G01N 33/5088 | (2013.01) | ||
| C07K2319/31 | (2013.01) | ||
| C07K2319/30 | (2013.01) | ||
| G01N2500/04 | (2013.01) | ||
| C07K 14/71 | (2013.01) | ||
| A61K 38/1796 | (2013.01) | ||
| G01N 33/80 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Patento numeris | 3320911 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17182870.0 |
| Europos patento paraiškos padavimo data | 2007-12-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-05-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-12-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 875682 P | 2006-12-18 | US |
| (72) |
SHERMAN, Matthew L. , US
|
| (73) |
Acceleron Pharma Inc. ,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS |
| ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS |